Audience for the document: Share Class: Language of the document:


Share Class: Language of the document:

Change Details

If you need to change your email address please contact us.
You are ready to start subscribing.
Get started by going to our products or insights section to follow what you're interested in.

Products Insights

GIPS® Information

T. Rowe Price ("TRP") claims compliance with the Global Investment Performance Standards (GIPS®) and has prepared and presented this report in compliance with the GIPS standards. T. Rowe Price has been independently verified for the twenty four-year period ended June 30, 2020, by KPMG LLP. The verification report is available upon request. A firm that claims compliance with the GIPS standards must establish policies and procedures for complying with all the applicable requirements of the GIPS standards. Verification provides assurance on whether the firm’s policies and procedures related to composite and pooled fund maintenance, as well as the calculation, presentation, and distribution of performance, have been designed in compliance with the GIPS standards and have been implemented on a firm-wide basis. Verification does not provide assurance on the accuracy of any specific performance report.

TRP is a U.S. investment management firm with various investment advisers registered with the U.S. Securities and Exchange Commission, the U.K. Financial Conduct Authority, and other regulatory bodies in various countries and holds itself out as such to potential clients for GIPS purposes. TRP further defines itself under GIPS as a discretionary investment manager providing services primarily to institutional clients with regard to various mandates, which include U.S, international, and global strategies but excluding the services of the Private Asset Management group.

A complete list and description of all of the Firm's composites and/or a presentation that adheres to the GIPS® standards are available upon request. Additional information regarding the firm's policies and procedures for calculating and reporting performance results is available upon request

Other Literature

You have successfully subscribed.

Notify me by email when
regular data and commentary is available
exceptional commentary is available
new articles become available

Thank you for your continued interest

Please enter valid search characters

2021 Global Market Outlook


New coronavirus vaccines offer a potential lift for economies in 2021 and could shift spending from firms that gained during the pandemic to cyclical names damaged by it. Low yields and tighter credit spreads could make attractive fixed income returns harder to find. Tensions between the U.S. and China are a potential flashpoint.

Get a clear picture of what recovery might look like.
Balance disruptive growth with value investment opportunities.
Seek fixed income yield—with acceptable risk—in today’s markets.
Find the signal in the noise with our take on the key issues.

2021 Global Market Outlook

Watch our video collection.

Click to read 2021 Global Market Outlook


Asia ex-Japan: Constructive Outlook for Equiti...

Asia ex-Japan: Constructive Outlook for Equities in 2021

Asia ex-Japan: Constructive Outlook for Equities in 2021

High-quality growth businesses on reasonable multiples

By Anh Lu

Anh Lu Portfolio Manager


China Market Outlook 2021

China Market Outlook 2021

China Market Outlook 2021

Improving fundamentals are likely to be sustained.

By Wenli Zheng

Wenli Zheng Regional Portfolio Manager

30 November 2020 / VIDEO

What COVID-19 Vaccines Could Mean for Markets

What COVID-19 Vaccines Could Mean for Markets

What COVID-19 Vaccines Could Mean for Markets

By Sébastien Page

Sébastien Page Head of Global Multi-Asset